NCT01314339View on ClinicalTrials.gov

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

February 28, 2006

Conditions
Fasting
Interventions
DRUG

Desloratadine

Desloratadine Tablets, 5 mg

Trial Locations (1)

33901

SFBC, Ft. Myers, Inc.,, Fort Myers

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY